Company Monitoring Page for Roche

latest headlines for company on cafepharma

Real threat to Opdivo’s small-cell chances will come from elsewhere
EP Vantage
Tue, 10/16/18 - 09:42 am
Tags:
Bristol-Myers Squibb, Opdivo, Small-Cell Lung Cancer, FDA, Tecentriq, Roche
Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could help
Fierce Pharma
Mon, 10/15/18 - 11:47 pm
Tags:
Roche, Kadcyla, Herceptin, BRCA-mutant breast cancer
Roche puts up $125M to expand SQZ cell therapy pact
Fierce Biotech
Mon, 10/15/18 - 12:03 pm
Tags:
Roche, SQZ Biotech, cell therapy
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
BioSpace
Thu, 10/11/18 - 09:38 am
Tags:
Pfizer, Amgen, Roche, FDA, social media, biosimilars
Roche and Novartis Strengthen Their Presence in the MS Market
BioSpace
Thu, 10/11/18 - 09:35 am
Tags:
Genentech, Roche, Ocrevus, Novartis, siponimod, FDA, MS, multiple sclerosis
Roche gets option to Ionis' antisense dry AMD candidate
BioCentury
Wed, 10/10/18 - 10:51 pm
Tags:
Roche, Ionis Pharmaceuticals, IONIS-FB-LRx, antisense, dry age-related macular degeneration
Roche unveils long-term data from MS blockbuster Ocrevus
Pharmaforum
Wed, 10/10/18 - 10:24 am
Tags:
Roche, Ocrevus, relapsing multiple sclerosis, MS
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
Fierce Pharma
Tue, 10/9/18 - 12:01 pm
Tags:
Celltrion, Roche, biosimilars, Rituxan, FDA, advisory panels
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom
Xconomy
Thu, 10/4/18 - 06:52 pm
Tags:
hemophilia A, FDA, Roche, Hemlibra
Trial shows Roche’s new flu drug helps reduce symptoms in at-risk patients
Pharmaforum
Thu, 10/4/18 - 09:46 am
Tags:
Roche, Flu, influenza, baloxavir marboxil
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
Fierce Pharma
Wed, 10/3/18 - 11:49 am
Tags:
Roche, Novartis, Xolair, Xolair pen, FDA
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
CP Wire
Tue, 10/2/18 - 12:02 pm
Tags:
Roche, Go Therapeutics, drug development, bispecific antibodies
Tue, 10/2/18 - 09:58 am
Tags:
Go Therapeutics, Roche
Roche pays €70M upfront for Tusk’s preclinical Treg depleter
Fierce Biotech
Sat, 09/29/18 - 12:03 am
Tags:
Roche, Tusk Therapeutics, M&A
Tecentriq sets the bar in small-cell lung cancer
Biopharma Dive
Tue, 09/25/18 - 11:08 pm
Tags:
Roche, Tecentriq, Small-Cell Lung Cancer
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
Mon, 09/24/18 - 03:37 pm
Tags:
UK, Roche, Avastin, wet age-related macular degeneration, Novartis, Bayer
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Xconomy
Mon, 09/24/18 - 03:32 pm
Tags:
Roche, entrectinib, Ignyta, FDA, non-small cell lung cancer
Roche aims to improve cancer treatments with DNA blood test
Pharmaforum
Mon, 09/24/18 - 09:54 am
Tags:
Roche, diagnostics, cancer, personalized medicine, solid tumors, FoundationOne Liquid
Roche tackles clinical trial matching challenge
Fierce Biotech
Tue, 09/18/18 - 04:26 pm
Tags:
Roche, clinical trials, patients, physicians
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Yahoo/Zacks.com
Sat, 09/15/18 - 02:19 pm
Tags:
Roche, Genentech, FDA, Actemra, systematic juvenile idiopathic arthritis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.